Prognostic impact of rapid reduction of involved free light chains in multiple myeloma patients under first-line treatment with Bendamustine, Prednisone, and Bortezomib (BPV)

ConclusionThese results indicate that a rapid decrease in the iFLC on day 8 is an early prognostic marker for newly diagnosed MM pts undergoing BPV treatment.

http://link.springer.com/10.1007/s00432-020-03504-3

Source: Journal of Cancer Research and Clinical Oncology - January 12, 2021 Category: Cancer & Oncology Source Type: research